AR124242A2 - PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS - Google Patents
PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERSInfo
- Publication number
- AR124242A2 AR124242A2 ARP210103364A ARP210103364A AR124242A2 AR 124242 A2 AR124242 A2 AR 124242A2 AR P210103364 A ARP210103364 A AR P210103364A AR P210103364 A ARP210103364 A AR P210103364A AR 124242 A2 AR124242 A2 AR 124242A2
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- present
- relates
- cancers
- tumor
- Prior art date
Links
Abstract
La presente invención se relaciona con péptidos, proteínas, ácidos nucleicos y células para usar en métodos inmunoterapéuticos. En particular, la presente invención se relaciona con la inmunoterapia de cáncer. La presente invención además se relaciona con epitopes peptídicos de células T asociados a tumor, solos o en combinación con otros péptidos asociados a tumor que por ejemplo pueden servir como ingredientes farmacéuticos activos de composiciones de vacuna que estimulan respuestas inmunológicas antitumorales, a para estimular a células T ex vivo y transferirlas a los pacientes. Los péptidos unidos a las moléculas del complejo mayor de histocompatibilidad (MHC), o los péptidos como tal, también pueden ser blancos de anticuerpos, receptores solubles de células T, y de otras moléculas de unión.The present invention relates to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that, for example, can serve as active pharmaceutical ingredients of vaccine compositions that stimulate antitumor immune responses, to stimulate cells T ex vivo and transfer them to patients. Peptides bound to major histocompatibility complex (MHC) molecules, or peptides themselves, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562188870P | 2015-07-06 | 2015-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR124242A2 true AR124242A2 (en) | 2023-03-01 |
Family
ID=59981555
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160102025A AR105252A1 (en) | 2015-07-06 | 2016-07-04 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGIC CANCER AND OTHER CANCER |
ARP210103364A AR124242A2 (en) | 2015-07-06 | 2021-12-03 | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS |
ARP210103365A AR124243A2 (en) | 2015-07-06 | 2021-12-03 | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERS |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160102025A AR105252A1 (en) | 2015-07-06 | 2016-07-04 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGIC CANCER AND OTHER CANCER |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210103365A AR124243A2 (en) | 2015-07-06 | 2021-12-03 | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERS |
Country Status (1)
Country | Link |
---|---|
AR (3) | AR105252A1 (en) |
-
2016
- 2016-07-04 AR ARP160102025A patent/AR105252A1/en unknown
-
2021
- 2021-12-03 AR ARP210103364A patent/AR124242A2/en unknown
- 2021-12-03 AR ARP210103365A patent/AR124243A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR124243A2 (en) | 2023-03-01 |
AR105252A1 (en) | 2017-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017009616A2 (en) | Peptides and combination of peptides and scaffolds for immunotherapy against renal cell carcinoma (rcc) and other cancers | |
AR127119A2 (en) | NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | |
CO2018002202A2 (en) | Peptides and combinations of peptides for immunotherapy against prostate cancer and other types of cancer | |
CL2021000981A1 (en) | New peptides and peptide combinations for use in immunotherapy against esophageal and other cancers. (divisional application no. 201703361) | |
CO2017008902A2 (en) | Peptides and new combinations of peptides for immunotherapy against lung cancer, including amicrocytic lung cancer and other types of cancer | |
CO2018000252A2 (en) | Peptides and combinations of peptides for immunotherapy against epithelial ovarian cancer and other types of cancer | |
CO2018003860A2 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other types of cancer | |
PE20181164A1 (en) | NEW PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCERS | |
CO2018010284A2 (en) | Treatments against uterine cancer | |
CO2017012891A2 (en) | Peptides and combinations of peptides for immunotherapy against ovarian cancer and other types of cancer | |
AR103220A1 (en) | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (CHC) AND OTHER TYPES OF CANCER | |
CO2018000245A2 (en) | Peptides and combinations of peptides for immunotherapy against pancreatic cancer and other types of cancer | |
CR20190388A (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
CR20220115A (en) | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (Div. 2017-522) | |
CO2018002902A2 (en) | Peptides and peptide combinations for the immunotherapeutic treatment of various types of cancer | |
CR20210167A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers | |
CO2018012294A2 (en) | Immunotherapy against melanoma and other types of cancer | |
CL2023001324A1 (en) | Peptides, combinations, cells for immunotherapy against bladder cancer and other cancers | |
CR20190094A (en) | Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers | |
CO2018004869A2 (en) | Peptides and combination of peptides for immunotherapy against various types of cancer | |
CO2017009101A2 (en) | Peptides and peptide combination | |
CO2017010830A2 (en) | Peptides and combinations of peptides and supports | |
CO2017003772A2 (en) | Peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers | |
AR124242A2 (en) | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS | |
AR122218A2 (en) | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |